Dividends • Protagonist Therapeutics

PTGX

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

See below the complete and updated table with all dividends paid and declared history, etc